Navigation Links
Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
Date:9/13/2007

SAN DIEGO, Sept. 13 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that the company is scheduled to provide a corporate overview of its clinical development and discovery programs at four upcoming investor conferences:

-- ThinkEquity Partners' 5th Annual Growth Conference

Presentation: Monday, September 17, 2007 at 10:00 a.m. Pacific Time

(1:00 p.m. Eastern Time) at the St. Regis Hotel in San Francisco

Presenting: Jack Lief, Arena's President and Chief Executive Officer

-- Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference 2007

Presentation: Wednesday, September 19, 2007 at 11:20 a.m. British

Summer Time (6:20 a.m. Eastern Time, 3:20 a.m. Pacific Time) at the

Merrill Lynch Financial Centre in London

Presenting: Jack Lief, Arena's President and Chief Executive Officer

-- A.G. Edwards' Emerging Growth Conference 2007

Presentation: Wednesday, September 19, 2007 at 12:30 p.m. Eastern Time

(9:30 a.m. Pacific Time) at the New York Palace Hotel in New York City

Presenting: Robert E. Hoffman, Arena's Vice President, Finance and

Chief Financial Officer

-- Maxim Group Growth Conference

Presentation: Thursday, September 20, 2007 at 10:30 a.m. Eastern Time

(7:30 a.m. Pacific Time) at the Grand Hyatt Hotel in New York City

Presenting: Robert E. Hoffman, Arena's Vice President, Finance and

Chief Financial Officer

A live audio webcast of each presentation will be available under the investor relations section of Arena's website at http://www.arenapharm.com. Pleas
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...3/PRNewswire/--Reportlinker.comannouncesthatanewma... MedicalNonwovenDisposables-AWorldwideMarketRevie...dical-Nonwoven-Disposables---A-Worldwide-Market-Re...amp;utm_campaign=prnewswire ,, Withincrease...fectinhealthcareandhospitalfacilities,nonwovenshas...
(Date:11/23/2009)...ov.23/PRNewswire/--BridgePointMedicalannouncedtoda...foritscoronaryandperipheralChronicTotalOcclusion(C...ssingCatheterandtheStingray®CTORe-EntrySystem...etersthataredesignedtonavigatehighlydiseasedarteri...tyandstenting. ,, TheNationalHeart,LungandBlood...
(Date:11/23/2009)....,Nov.23/PRNewswire/--LightSciencesOncology,Inc.(L...noftheBoard,Elekta,toanewlycreatedseatonitsboardof...smedical-productcompanies,includingElekta,tomarket...ngsadditionalstrengthinbusinessdevelopmenttotheboa...dighisaworldleaderincancer-therapybusinessdevelopm...
Breaking Medicine Technology:Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 2Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 3Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 4Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 5Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 6Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 7Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 8BridgePoint Medical(R) Receives European CE Mark for Stingray(R) and CrossBoss(TM) for Opening Completely Blocked Arteries 2Light Sciences Oncology Elects Akbar Seddigh, Chairman of Elekta AB to Its Board of Directors 2Ratcliff Promotes Jorge Burbano to Senior Associate 3B Tess Kavanagh and Tony Keung to Associate 12477 1Ratcliff Promotes Jorge Burbano to Senior Associate 3B Tess Kavanagh and Tony Keung to Associate 12477 2Cambrex Regains Compliance With Revised NYSE Listing Standards 47999 1NxStage to Present at the William Blair Growth Stock Conference 47994 1NxStage to Present at the William Blair Growth Stock Conference 47994 2
...rk., Oct. 8 A research study,at the University of...to,establish one of the largest and most rapidly a...east cancer occurrence. Spit for the Cure involve...of women and is being conducted with the support o...ure. The saliva samples will be used to,create a D...
...e 3 clinical development program will examine HZT-... mild to moderate pain -, PALO ALTO, Calif., Oct....iopharmaceutical company, today announced that it ...otocol HZ-CA-304) of its lead,product candidate HZ...steroidal anti-inflammatory drug) designed to be "...
Other Medicine Technology:Spit for the Cure Offers Unique Opportunity for Women to Participate in Breast Cancer Research 2Horizon Therapeutics Initiates Long-Term Phase 3 Safety Study for Lead Product Candidate HZT-501 2Horizon Therapeutics Initiates Long-Term Phase 3 Safety Study for Lead Product Candidate HZT-501 3
(Date:11/23/2009)...drug approval process in United States, researcher...s) -- Problems with the popular arthritis drug Vio...oke and death, were known for years before the dru...a new report says. , Contrary to claims by the...ects were evident in 2000, a year after the drug w...
(Date:11/23/2009)...ityBanksin Washington D.C. , NewYork , N.Y.... IntendedtoSpurEconomicGrowthandRevitalization ...Vita,thenation,sleadingproviderofdialysisservices,...ignedtocreatejobsandspurrevitalizationinminorityco...ommunityandminority-ownedbanks.DaVitahasdonated$5m...
(Date:11/23/2009)...re/-- ,, WHAT: ,, TheBerylInstitute, ther...ation,sleadinghealthcareexclusivecallcenter,isspon...ineverygenerationwithapositivecustomerserviceexper...thisWebinarwillsupplementHowe,sJune2009whitepaper,...hdiscusseshowconsumerswillultimatelytransformhealt...
(Date:11/23/2009)...3/PRNewswire-USNewswire/--SouthamptonHospitalannou...ontofundanewEmergencyDepartment.Thegiftisthelarges...lmostdoubletheexistingspaceandgreatlyexpanditsdeli...hForkofLongIsland. ,, ScheduledforcompletionbyM...willprovideacentralizedtraumanurses,stationandtria...
(Date:11/23/2009)...r Science Writings at Stevens Institute of Technol... Robert Wright, journalist and founder, Blogginghe.... at the Babbio Center for Technology Management, ... and the media., In his new book "The Evolution ... renowned for his popular works on evolutionary ps...
Breaking Medicine News(10 mins):Health News: Vioxx Problems Known Years Before Recall 2Health News: Vioxx Problems Known Years Before Recall 3Health News: Vioxx Problems Known Years Before Recall 4Health News:DaVita Launches Minority Bank Initiative with $5 Million Investment in Underserved Communities Across the Country 2Health News:DaVita Launches Minority Bank Initiative with $5 Million Investment in Underserved Communities Across the Country 3Health News:Tips to Improve Healthcare Customer Service Across All Generations 2Health News:Southampton Hospital Receives $5 Million Gift for New Emergency Department 2
...y boy? Tuck into the burgers, fries and ice cream....ht//. It works for cows, according to John Ro...rganisation Dexcel. "And we would expect what hold... 18-year research project from 1986 to 2004. ...
...pany Lupin Ltd today said it has recieved the fina...w Drug Application (ANDA) of hypertension medicine...e Bombay Stock Exchange that the approval is for t... and its market is estimated to be about 300 milli...
... out in the AII India Institute of Medical Science...fficials said today. // The blaze broke out in...a suspected short circuit shortly after 1 a.M., th... functioning in four rooms on the ground floor of ...
...ed women's with damaged or missing wombs by saying...ome possible to have children normally. // Af...hers recommended that womb transplantation would b...n also be benefited from womb transplants since th...
...patients in Ulster Hospital were been faced by the... Another study by the BMA in Northern Ireland, ...octors were also been found. A postal questionnair...evealed their terrible experience of verbal abuse ...
...ent study done in UK it was found that mobile phon... from lightning strikes//. Doctors have warned tha... used in stormy weather conditions. The charge fr...e strike inside the body and result in internal in...
Other Medicine News:Health News:Does Weight of the Mother Determine the Sex of the Baby? 2
Auszyme Monoclonal
Total Prostate Specific Antigen
...prehensive line of pregnancy tests including rapid...one-step stick and cassette formats. The Clearview... is a 25 mIU urine test in a convenient stick form...or urine specimens. Wampole PreVue offers 25 mIU s...
BioCheck hCG ELISA
Medicine Products: